Clinical Trial Update: Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X) [Phase 3]

View source ↗

Summary

Phase 3 trial update report on long-term safety of gevokizumab in chronic non-infectious uveitis, with the study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Gevokizumab (gevokizumab)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Chronic Uveitis | Phase 3 | Status: TERMINATED